96 related articles for article (PubMed ID: 23712292)
21. High-Intensity Chemotherapy is Associated with Better Prognosis in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma: A 10-Year Single-Center Retrospective Cohort Study.
Ma X; Xu Y; Zhang W; Wang J; Cao X; Chen Y; He A; Liu J; Wang J; Zhao W; Yang Y
Med Sci Monit; 2016 May; 22():1792-800. PubMed ID: 27232105
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcomes with HLX01 (HanliKang
Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
[TBL] [Abstract][Full Text] [Related]
23. CT-based body composition in diffuse large B cell lymphoma patients: changes after treatment and association with survival.
Pirosa MC; Esposito F; Raia G; Chianca V; Cozzi A; Ruinelli L; Ceriani L; Zucca E; Del Grande F; Rizzo S
Radiol Med; 2023 Dec; 128(12):1497-1507. PubMed ID: 37752299
[TBL] [Abstract][Full Text] [Related]
24. Mature outcomes and prognostic indices in diffuse large B-cell lymphoma in Malawi: a prospective cohort.
Painschab MS; Kasonkanji E; Zuze T; Kaimila B; Tomoka T; Nyasosela R; Nyirenda R; Dhungel BM; Mulenga M; Chikasema M; Tewete B; Mtangwanika A; Chiyoyola S; Mhango W; Chimzimu F; Kampani C; Krysiak R; Shea TC; Montgomery ND; Fedoriw Y; Gopal S
Br J Haematol; 2019 Feb; 184(3):364-372. PubMed ID: 30450671
[TBL] [Abstract][Full Text] [Related]
25. Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
Fenske TS; Hari PN; Carreras J; Zhang MJ; Kamble RT; Bolwell BJ; Cairo MS; Champlin RE; Chen YB; Freytes CO; Gale RP; Hale GA; Ilhan O; Khoury HJ; Lister J; Maharaj D; Marks DI; Munker R; Pecora AL; Rowlings PA; Shea TC; Stiff P; Wiernik PH; Winter JN; Rizzo JD; van Besien K; Lazarus HM; Vose JM
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1455-64. PubMed ID: 19822306
[TBL] [Abstract][Full Text] [Related]
26. High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy.
Kusano Y; Yokoyama M; Terui Y; Inoue N; Takahashi A; Yamauchi H; Tsuyama N; Nishimura N; Mishima Y; Takeuchi K; Hatake K
Blood Cancer J; 2017 Sep; 7(9):e614. PubMed ID: 28960192
[No Abstract] [Full Text] [Related]
27. [Clinical analysis of the character and prognostic factors of 23 cases of mantle cell lymphoma].
Liang R; Wang Z; Zhu MN; Hao CX; Zhang N; Wang JH; Zhang T; Yang L; Gu HT; Dong BX; Bai QX; Gao GX; Chen XQ
Zhonghua Xue Ye Xue Za Zhi; 2016 Jun; 37(6):491-6. PubMed ID: 27431074
[TBL] [Abstract][Full Text] [Related]
28. Higher Mortality in Patients With Diffuse Large B-cell Lymphoma Pre-Existing Arterial Hypertension-Real World Data of the Polish Lymphoma Research Group.
Szmit S; Długosz-Danecka M; Drozd-Sokołowska J; Joks M; Szeremet A; Jurczyszyn A; Jurczak W
Heart Lung Circ; 2024 May; 33(5):675-683. PubMed ID: 38616466
[TBL] [Abstract][Full Text] [Related]
29. TP53 mutations predict for poor outcomes in patients with newly diagnosed aggressive B-cell lymphomas in the current era.
Landsburg DJ; Morrissette JJ; Nasta SD; Barta SK; Schuster SJ; Svoboda J; Chong EA; Bagg A
Blood Adv; 2023 Dec; 7(23):7243-7253. PubMed ID: 37851898
[TBL] [Abstract][Full Text] [Related]
30. Additional rituximab-CHOP (R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysis.
Hong J; Kim AJ; Park JS; Lee SH; Lee KC; Park J; Sym SJ; Cho EK; Shin DB; Lee JH
Korean J Hematol; 2010 Dec; 45(4):253-9. PubMed ID: 21253427
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of the red blood cell distribution width in diffuse large B-cell lymphoma patients.
Zhou S; Fang F; Chen H; Zhang W; Chen Y; Shi Y; Zheng Z; Ma Y; Tang L; Feng J; Zhang Y; Sun L; Chen Y; Liang B; Yu K; Jiang S
Oncotarget; 2017 Jun; 8(25):40724-40731. PubMed ID: 28388534
[TBL] [Abstract][Full Text] [Related]
32. Steroid-Induced Hyperglycemia and Its Effect on Outcomes of R-CHOP Chemotherapy for Diffuse Large B-Cell Lymphoma.
Kristjanson M; Lambert P; Decker KM; Bruin S; Tingey E; Skrabek P
Curr Oncol; 2023 Nov; 30(12):10142-10151. PubMed ID: 38132372
[TBL] [Abstract][Full Text] [Related]
33. Improved Progression-Free Survival for Bulky and Non-Bulky Advanced Stage Diffuse Large B-Cell Lymphoma With Consolidative Radiation Therapy: A Bi-Institutional Analysis.
Syed YA; Jiang C; Switchenko J; Kirmani K; Kelsey C; Khan MK
Cureus; 2021 Aug; 13(8):e17107. PubMed ID: 34527492
[TBL] [Abstract][Full Text] [Related]
34. Long-Term Safety and Effectiveness of Rituximab Biosimilar RTXM83: A Retrospective Extension Study in Brazilian Patients with Diffuse Large B-Cell Lymphoma.
Delamain MT; Cardoso ACF; Pericole FV; da Silva Araújo SS; Fogliatto L; Higashi M; Pereira J; da Silva RL; Werutsky G; de Paulo Giacon Radtke P; Salvino MA; Castilho V
Oncol Ther; 2024 Jun; ():. PubMed ID: 38829416
[TBL] [Abstract][Full Text] [Related]
35. Clinical Features and Outcomes of Primary Breast Diffuse Large B-Cell Lymphoma: A Matched-Pair Study.
Teng LC; Liao YM; Gau JP; Hsiao TH; Chen TC; Chen MH; Yeh SP; Teng CJ
Clin Med Insights Oncol; 2023; 17():11795549231203142. PubMed ID: 37905234
[TBL] [Abstract][Full Text] [Related]
36. Are changes in patient-reported outcomes prognostic for diffuse large B-Cell lymphoma survival? Results from the GOYA trial.
Yan JT; Bel C; Trask PC; Lo E
J Patient Rep Outcomes; 2024 Mar; 8(1):31. PubMed ID: 38498084
[TBL] [Abstract][Full Text] [Related]
37. Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era.
Tao L; Clarke CA; Rosenberg AS; Advani RH; Jonas BA; Flowers CR; Keegan THM
Br J Haematol; 2017 Jul; 178(1):72-80. PubMed ID: 28542862
[TBL] [Abstract][Full Text] [Related]
38. The impact of marginalization on diffuse large B-cell lymphoma overall survival: a retrospective cohort study.
Arya S; Mozessohn L; Gong I; Faught N; Liu N; Singh S; Chan K; Cheung MC
Leuk Lymphoma; 2024 May; 65(5):629-637. PubMed ID: 38265355
[TBL] [Abstract][Full Text] [Related]
39. Survival after diffuse large B-cell lymphoma among children, adolescents, and young adults in California, 2001-2014: A population-based study.
Abrahão R; Ribeiro RC; Lichtensztajn DY; Rosenberg AS; Keegan THM
Pediatr Blood Cancer; 2019 Apr; 66(4):e27559. PubMed ID: 30511461
[TBL] [Abstract][Full Text] [Related]
40. Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance.
Boyle S; Tobin JWD; Perram J; Hamad N; Gullapalli V; Barraclough A; Singaraveloo L; Han MH; Blennerhassett R; Nelson N; Johnston AM; Talaulikar D; Karpe K; Bhattacharyya A; Cheah CY; Subramoniapillai E; Bokhari W; Lee C; Hawkes EA; Jabbour A; Strasser SI; Chadban SJ; Brown C; Mollee P; Hapgood G
Hemasphere; 2021 Nov; 5(11):e648. PubMed ID: 34651103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
